Bluejay Diagnostics, Inc. (BJDX) - Pendapatan perusahaan

Intense competition in the rapid test segment is putting pressure on Bluejay Diagnostics (BJDX) gross sales revenue, which remains at 0.00. The lack of operating income and reliance on equity issuance confirm financial instability. Simultaneously, Bluejay Diagnostics is implementing eco-friendly packaging to reduce energy costs. This chart illustrates current cash flow trends, helping to assess capital sustainability.

BJDX - Dodolan perusahaan Bluejay ing rentang 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Bluejay Diagnostics

- nilai pasar lan prakiraan target analis:

Bagan bursa Bluejay Diagnostics Corp|BJDX - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Nilai pasar Bluejay Diagnostics, Inc.|BJDX - Nilai Total Perusahaan

- informasi kapitalisasi buku:

Aset Bersih saben Siji Saham Bluejay Diagnostics|BJDX - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku bluejaydx.com|BJDX - Total Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Utang marang Modal Bluejay Diagnostics|BJDX - Utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Bluejay Diagnostics Inc|BJDX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Bluejay Diagnostics, Inc.|BJDX - Kewajiban jangka dawa perusahaan|Utang jangka cendhak Bluejay Diagnostics|Rasio jangkoan perantara bluejaydx.com

- statistik bathi lan rasio pasar:

BJDX - Bathi resik|Prakiraan bathi resik Bluejay Diagnostics|BJDX - Pangali P/E|Kapitalisasi marang proyeksi bathi bluejaydx.com|BJDX - Pangali PEG|Pangali EV/EBITDA Bluejay Diagnostics, Inc.|BJDX - Bathi operasional EBITDA|Bathi resik saben saham sajroning taun lumaku Bluejay Diagnostics|BJDX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan bluejaydx.com|BJDX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Bluejay Diagnostics

- rincian pendapatan lan dodolan emiten:

BJDX - Pendapatan perusahaan|Dodolan mangsa ngarep perusahaan Bluejay Diagnostics Corp|BJDX - Kapitalisasi marang pendapatan|Rasio rega marang pendapatan sing dikarepake Bluejay Diagnostics, Inc.

Ringkesan analisis perusahaan:BJDX, Bluejay Diagnostics Corp

This indicator is based on the aggregation of daily cash inflows from product sales, which allows for the neutralization of random market noise and the identification of true business activity cycles. Analyzing the sales velocity of Bluejay Diagnostics (BJDX) helps assess the company's commercial resilience amid fierce competition and risks associated with FDA approval of sepsis tests, thereby determining the entry point into the asset.

Perusahaan pesaing